Geneva Biotech Center (GBC) SA Information

Founded in 2013, the Geneva Biotech Center responds to the growing trend of pharmaceutical companies outsourcing research and development capabilities. Its core operational structure consists of business and scientific experts passionate about their work, each with more than twenty years’ experience, supported by a wide network of specialized consultants, CROs and affiliates. The team’s expertise covers the part of the drug discovery pipeline with the highest valorization potential, from late preclinical development to clinical proof of concept. The GBC selects promising projects, builds a de-risked development path according to pharmaceutical quality standards, and offers optimal development and valorization to its academic, commercial and financial partners. With its translational and custom-made approach, which includes all the key phases of research and drug development within a dynamic and flexible organization, the GBC provides solid foundations for innovative therapies in disease areas with a high unmet medical need.